Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13177
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChowchaikong N.
dc.contributor.authorNilwarangkoon S.
dc.contributor.authorLaphookhieo S.
dc.contributor.authorTanunyutthawongse C.
dc.contributor.authorWatanapokasin R.
dc.date.accessioned2021-04-05T03:22:37Z-
dc.date.available2021-04-05T03:22:37Z-
dc.date.issued2018
dc.identifier.issn10196439
dc.identifier.other2-s2.0-85045395183
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13177-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85045395183&doi=10.3892%2fijo.2018.4353&partnerID=40&md5=79a225755790f03dd39f67ff640236ce
dc.description.abstractColorectal cancer, which is the third most common type of cancer diagnosed in both men and women, is the leading cause of cancer-related deaths worldwide. Cowanin is a pure compound extracted from Garcinia cowa Roxb., a tree species present in Thailand, Malaysia and Myanmar. The crude extract has been demonstrated to have antitumor activity, inflammation induction, antibacterial activity, anti-inflammatory activity and antimalarial activity. In the present study, the effects of cowanin on apoptosis induction and on the apoptosis- related and mitogen-Activated protein kinase (MAPK) pathways were investigated in the LoVo human colorectal cancer cell line. The cytotoxicity of cowanin in LoVo cells was determined by MTT assay. Hoechst 33342 and JC-1 staining were used to determine nuclear morphological changes and mitochondrial membrane potential, respectively. The expression levels of BCL2 apoptosis regulator (Bcl-2) family, MAPK and AKT serine/threonine kinase 1 (Akt) pathway proteins following cowanin treatment were determined by western blot analysis. The results demonstrated that cowanin inhibited cell proliferation and induced cell death via the apoptosis pathway. Cowanin treatment increased BCL2 associated X (Bax) and decreased Bcl-2 expression. In addition, cowanin activated caspase-9, -7 and poly-ADP-ribose-polymerase expression. Furthermore, cowanin decreased the levels of phosphorylated extracellular signal-regulated kinase (p-ERK), p-Akt, p-3-phosphoinositide-dependent protein kinase-1, while it increased p-p38 expression, thus resulting in the induction of apoptosis. In conclusion, cowanin inhibited cell proliferation and induced apoptosis of LoVo cells via the MAPK and Akt signaling pathways. Notably, inhibition of p38 by using a p38 inhibitor (SB203580) prevented the cowanin-induced apoptosis in LoVo cells. These results suggested that cowanin may be a potential candidate for the treatment of colorectal cancer and provided important information on the molecular mechanisms underlying its antitumor activity. © 2018 Spandidos Publications. All rights reserved.
dc.subjectantineoplastic agent
dc.subjectcaspase 7
dc.subjectcaspase 9
dc.subjectcowanin
dc.subjecthoe 33342
dc.subjectmitogen activated protein kinase
dc.subjectmitogen activated protein kinase p38 inhibitor
dc.subjectnicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
dc.subjectphosphoinositide dependent protein kinase 1
dc.subjectprotein Bax
dc.subjectprotein bcl 2
dc.subjectprotein kinase B
dc.subjectunclassified drug
dc.subjectxanthone derivative
dc.subject4 (4 fluorophenyl) 2 (4 methylsulfinylphenyl) 5 (4 pyridyl)imidazole
dc.subjectCASP7 protein, human
dc.subjectCASP9 protein, human
dc.subjectcaspase 7
dc.subjectcaspase 9
dc.subjectcowaniin
dc.subjectimidazole derivative
dc.subjectmitogen activated protein kinase p38
dc.subjectnicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase
dc.subjectprotein kinase B
dc.subjectpyridine derivative
dc.subjecttannin derivative
dc.subjectAkt signaling
dc.subjectantiproliferative activity
dc.subjectapoptosis
dc.subjectArticle
dc.subjectcell death
dc.subjectcell nucleus
dc.subjectcell structure
dc.subjectcell survival
dc.subjectcell viability
dc.subjectcontrolled study
dc.subjectdrug cytotoxicity
dc.subjectdrug mechanism
dc.subjectdrug structure
dc.subjecthuman
dc.subjecthuman cell
dc.subjectLoVo cell line
dc.subjectmitochondrial membrane potential
dc.subjectMTT assay
dc.subjectpriority journal
dc.subjectprotein expression level
dc.subjectprotein synthesis
dc.subjectWestern blotting
dc.subjectantagonists and inhibitors
dc.subjectcell cycle
dc.subjectcell proliferation
dc.subjectchemistry
dc.subjectcolorectal tumor
dc.subjectdrug effect
dc.subjectgene expression regulation
dc.subjectMAPK signaling
dc.subjectmetabolism
dc.subjecttumor cell line
dc.subjectCaspase 7
dc.subjectCaspase 9
dc.subjectCell Cycle
dc.subjectCell Line, Tumor
dc.subjectCell Proliferation
dc.subjectCell Survival
dc.subjectColorectal Neoplasms
dc.subjectGene Expression Regulation, Neoplastic
dc.subjectHumans
dc.subjectImidazoles
dc.subjectMAP Kinase Signaling System
dc.subjectp38 Mitogen-Activated Protein Kinases
dc.subjectPoly(ADP-ribose) Polymerases
dc.subjectProto-Oncogene Proteins c-akt
dc.subjectPyridines
dc.subjectTannins
dc.titleP38 inhibitor inhibits the apoptosis of cowanin-treated human colorectal adenocarcinoma cells
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationInternational Journal of Oncology. Vol 52, No.6 (2018), p.2031-2040
dc.identifier.doi10.3892/ijo.2018.4353
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.